[시장보고서]세계의 임상시험 아웃소싱 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2035년)

세계의 임상시험 아웃소싱 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2035년)

Clinical Trials Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

상품코드 : 1721211

리서치사 : Transparency Market Research

발행일 : 2025년 03월

페이지 정보 : 영문 213 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 7,939,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,050,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 16,160,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

임상시험 아웃소싱 시장 : 조사 범위

TMR의 "세계 임상시험 아웃소싱 시장" 보고서는 2025-2035년의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2019년부터 2035년까지의 세계 임상시험 아웃소싱 시장의 수익과 예측을 제공하고자 2025년을 기준 연도로, 2035년을 예측 연도로 삼고 있습니다. 또한, 2025-2035년 세계 임상시험 아웃소싱 시장의 CAGR(연평균 성장률)을 제시합니다.

본 보고서는 광범위한 1차 조사, KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 자료, 임상시험 등을 통해 아웃소싱 시장을 추론했습니다. 임상시험 아웃소싱 시장을 추론하였습니다.

시장 현황
2024년 시장 규모	507억 달러
2035년 시장 규모	1,019억 달러
CAGR	6.4%

이 보고서는 세계 임상시험 아웃소싱 시장의 경쟁 환경을 조사했습니다. 세계 임상시험 아웃소싱 시장에서 활동하는 주요 업체를 파악하고, 각 업체는 다양한 속성별로 프로파일링되어 있습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등 세계 임상시험 아웃소싱 시장의 기업 속성은 본 보고서에서 소개됩니다.

서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 서비스 유형별(2020년-2035년)
- 실험실 서비스
- 생체 분석 시험 서비스
- 분산형 임상시험 서비스
- 환자 모집
- 사이트 식별
- 분석 시험 서비스
- 임상시험 공급 및 물류 서비스
- 프로토콜 설계
- 임상시험 데이터 관리 서비스
- 의료기기 시험 서비스
- 기타
시장의 매력 분석 : 서비스 유형별

제7장 세계 시장 분석 및 예측 : 치료 영역별

서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 치료 영역별(2020년-2035년)
- 종양학
- 감염증
- 신경학
- 대사장애
- 면역학
- 심장병학
- 유전성 질환
- 여성 건강
- 기타
시장의 매력 분석 : 치료 영역별

제8장 세계 시장 분석 및 예측 : 용도별

서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 용도별(2020년-2035년)
- 소분자
- 단일클론항체
- 백신
- 세포 및 유전자 치료
- 기타
시장의 매력 분석 : 용도별

제9장 세계 시장 분석 및 예측 : 최종사용자별

서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 최종사용자별(2020년-2035년)
- 제약 및 바이오테크놀러지 기업
- 의료기기 제조업체
시장의 매력 분석 : 최종사용자별

제10장 세계 시장 분석 및 예측 : 지역별

주요 조사 결과
시장 매출 예측 : 지역별(2020년-2035년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
시장의 매력 : 지역별

제11장 북미 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 아시아태평양 시장 분석과 예측

제14장 라틴아메리카 시장 분석과 예측

제15장 중동 및 아프리카 시장 분석과 예측

제16장 경쟁 구도

시장 기업 : 경쟁 매트릭스(기업 Tier별, 규모별)
시장 점유율 분석 : 기업별(2024년)
기업 개요
- ICON plc
- IQVIA
- Thermo Fisher Scientific Inc.
- SGS Life Sciences
- Charles River Laboratories
- Parexel
- Syneos Health
- Medpace
- LabCorp
- KCR
- PRA Health Sciences
- WuXi AppTec
- Pharmaron
- Avance Clinical
- Pharmaron

LSH

영문 목차

영문목차

Clinical Trials Outsourcing Market - Scope of Report

TMR's report on the global clinical trials outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global clinical trials outsourcing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical trials outsourcing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the clinical trials outsourcing market.

Market Snapshot
Market Value in 2024	US$ 50.7 Bn
Market Value in 2035	US$ 101.9 Bn
CAGR	6.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global clinical trials outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global clinical trials outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global clinical trials outsourcing market.

The report delves into the competitive landscape of the global clinical trials outsourcing market. Key players operating in the global clinical trials outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global clinical trials outsourcing market profiled in this report.

Key Questions Answered in Global clinical trials outsourcing market Report:

What is the sales/revenue generated by clinical trials outsourcing across all regions during the forecast period?
What are the opportunities in the global clinical trials outsourcing market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Clinical Trials Outsourcing Market - Research Objectives and Research Approach

The comprehensive report on the global clinical trials outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global clinical trials outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global clinical trials outsourcing market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Clinical Trials Outsourcing Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Clinical Trials Outsourcing Market Analysis and Forecast, 2020-2035
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Key Industry Events
5.2. Impact Analysis
5.3. PESTEL Analysis
5.4. Regulatory Scenario by Key Countries/Regions
5.5. PORTER's Five Forces Analysis
5.6. Technological Advancements
5.7. Fund Raise/Investment Scenario

6. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Service Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Service Type, 2020-2035
- 6.3.1. Laboratory Services
- 6.3.2. Bioanalytical Testing Services
- 6.3.3. Decentralized Clinical Trial Services
- 6.3.4. Patient Recruitment
- 6.3.5. Site Identification
- 6.3.6. Analytical Testing Services
- 6.3.7. Clinical Trial Supply & Logistic Services
- 6.3.8. Protocol Designing
- 6.3.9. Clinical Trial Data Management Services
- 6.3.10. Medical Device Testing Services
- 6.3.11. Others
6.4. Market Attractiveness Analysis, by Service Type

7. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Therapeutic Area

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Therapeutic Area, 2020-2035
- 7.3.1. Oncology
- 7.3.2. Infectious Diseases
- 7.3.3. Neurology
- 7.3.4. Metabolic Disorders
- 7.3.5. Immunology
- 7.3.6. Cardiology
- 7.3.7. Genetic Diseases
- 7.3.8. Women's Health
- 7.3.9. Others
7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Application

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2035
- 8.3.1. Small Molecules
- 8.3.2. Monoclonal Antibodies
- 8.3.3. Vaccine
- 8.3.4. Cell & Gene Therapy
- 8.3.5. Others
8.4. Market Attractiveness Analysis, by Application

9. Global Clinical Trials Outsourcing Market Analysis and Forecast, by End-user

9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2035
- 9.3.1. Pharmaceutical and Biotech Companies
- 9.3.2. Medical Device Manufacturers
9.4. Market Attractiveness Analysis, by End-user

10. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2035
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region

11. North America Clinical Trials Outsourcing Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Service Type, 2020-2035
- 11.2.1. Laboratory Services
- 11.2.2. Bioanalytical Testing Services
- 11.2.3. Decentralized Clinical Trial Services
- 11.2.4. Patient Recruitment
- 11.2.5. Site Identification
- 11.2.6. Analytical Testing Services
- 11.2.7. Clinical Trial Supply & Logistic Services
- 11.2.8. Protocol Designing
- 11.2.9. Clinical Trial Data Management Services
- 11.2.10. Medical Device Testing Services
- 11.2.11. Others
11.3. Market Value Forecast, by Therapeutic Area, 2020-2035
- 11.3.1. Oncology
- 11.3.2. Infectious Diseases
- 11.3.3. Neurology
- 11.3.4. Metabolic Disorders
- 11.3.5. Immunology
- 11.3.6. Cardiology
- 11.3.7. Genetic Diseases
- 11.3.8. Women's Health
- 11.3.9. Others
11.4. Market Value Forecast, by Application, 2020-2035
- 11.4.1. Small Molecules
- 11.4.2. Monoclonal Antibodies
- 11.4.3. Vaccine
- 11.4.4. Cell & Gene Therapy
- 11.4.5. Others
11.5. Market Value Forecast, by End-user, 2020-2035
- 11.5.1. Pharmaceutical and Biotech Companies
- 11.5.2. Medical Device Manufacturers
11.6. Market Value Forecast, by Country, 2020-2035
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Service Type
- 11.7.2. By Therapeutic Area
- 11.7.3. By Application
- 11.7.4. By End-user
- 11.7.5. By Country

12. Europe Clinical Trials Outsourcing Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Service Type, 2020-2035
- 12.2.1. Laboratory Services
- 12.2.2. Bioanalytical Testing Services
- 12.2.3. Decentralized Clinical Trial Services
- 12.2.4. Patient Recruitment
- 12.2.5. Site Identification
- 12.2.6. Analytical Testing Services
- 12.2.7. Clinical Trial Supply & Logistic Services
- 12.2.8. Protocol Designing
- 12.2.9. Clinical Trial Data Management Services
- 12.2.10. Medical Device Testing Services
- 12.2.11. Others
12.3. Market Value Forecast, by Therapeutic Area, 2020-2035
- 12.3.1. Oncology
- 12.3.2. Infectious Diseases
- 12.3.3. Neurology
- 12.3.4. Metabolic Disorders
- 12.3.5. Immunology
- 12.3.6. Cardiology
- 12.3.7. Genetic Diseases
- 12.3.8. Women's Health
- 12.3.9. Others
12.4. Market Value Forecast, by Application, 2020-2035
- 12.4.1. Small Molecules
- 12.4.2. Monoclonal Antibodies
- 12.4.3. Vaccine
- 12.4.4. Cell & Gene Therapy
- 12.4.5. Others
12.5. Market Value Forecast, by End-user, 2020-2035
- 12.5.1. Pharmaceutical and Biotech Companies
- 12.5.2. Medical Device Manufacturers
12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 12.6.1. Germany
- 12.6.2. UK
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Service Type
- 12.7.2. By Therapeutic Area
- 12.7.3. By Application
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region

13. Asia Pacific Clinical Trials Outsourcing Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Service Type, 2020-2035
- 13.2.1. Laboratory Services
- 13.2.2. Bioanalytical Testing Services
- 13.2.3. Decentralized Clinical Trial Services
- 13.2.4. Patient Recruitment
- 13.2.5. Site Identification
- 13.2.6. Analytical Testing Services
- 13.2.7. Clinical Trial Supply & Logistic Services
- 13.2.8. Protocol Designing
- 13.2.9. Clinical Trial Data Management Services
- 13.2.10. Medical Device Testing Services
- 13.2.11. Others
13.3. Market Value Forecast, by Therapeutic Area, 2020-2035
- 13.3.1. Oncology
- 13.3.2. Infectious Diseases
- 13.3.3. Neurology
- 13.3.4. Metabolic Disorders
- 13.3.5. Immunology
- 13.3.6. Cardiology
- 13.3.7. Genetic Diseases
- 13.3.8. Women's Health
- 13.3.9. Others
13.4. Market Value Forecast, by Application, 2020-2035
- 13.4.1. Small Molecules
- 13.4.2. Monoclonal Antibodies
- 13.4.3. Vaccine
- 13.4.4. Cell & Gene Therapy
- 13.4.5. Others
13.5. Market Value Forecast, by End-user, 2020-2035
- 13.5.1. Pharmaceutical and Biotech Companies
- 13.5.2. Medical Device Manufacturers
13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Service Type
- 13.7.2. By Therapeutic Area
- 13.7.3. By Application
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region

14. Latin America Clinical Trials Outsourcing Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Service Type, 2020-2035
- 14.2.1. Laboratory Services
- 14.2.2. Bioanalytical Testing Services
- 14.2.3. Decentralized Clinical Trial Services
- 14.2.4. Patient Recruitment
- 14.2.5. Site Identification
- 14.2.6. Analytical Testing Services
- 14.2.7. Clinical Trial Supply & Logistic Services
- 14.2.8. Protocol Designing
- 14.2.9. Clinical Trial Data Management Services
- 14.2.10. Medical Device Testing Services
- 14.2.11. Others
14.3. Market Value Forecast, by Therapeutic Area, 2020-2035
- 14.3.1. Oncology
- 14.3.2. Infectious Diseases
- 14.3.3. Neurology
- 14.3.4. Metabolic Disorders
- 14.3.5. Immunology
- 14.3.6. Cardiology
- 14.3.7. Genetic Diseases
- 14.3.8. Women's Health
- 14.3.9. Others
14.4. Market Value Forecast, by Application, 2020-2035
- 14.4.1. Small Molecules
- 14.4.2. Monoclonal Antibodies
- 14.4.3. Vaccine
- 14.4.4. Cell & Gene Therapy
- 14.4.5. Others
14.5. Market Value Forecast, by End-user, 2020-2035
- 14.5.1. Pharmaceutical and Biotech Companies
- 14.5.2. Medical Device Manufacturers
14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Service Type
- 14.7.2. By Therapeutic Area
- 14.7.3. By Application
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region

15. Middle East & Africa Clinical Trials Outsourcing Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Service Type, 2020-2035
- 15.2.1. Laboratory Services
- 15.2.2. Bioanalytical Testing Services
- 15.2.3. Decentralized Clinical Trial Services
- 15.2.4. Patient Recruitment
- 15.2.5. Site Identification
- 15.2.6. Analytical Testing Services
- 15.2.7. Clinical Trial Supply & Logistic Services
- 15.2.8. Protocol Designing
- 15.2.9. Clinical Trial Data Management Services
- 15.2.10. Medical Device Testing Services
- 15.2.11. Others
15.3. Market Value Forecast, by Therapeutic Area, 2020-2035
- 15.3.1. Oncology
- 15.3.2. Infectious Diseases
- 15.3.3. Neurology
- 15.3.4. Metabolic Disorders
- 15.3.5. Immunology
- 15.3.6. Cardiology
- 15.3.7. Genetic Diseases
- 15.3.8. Women's Health
- 15.3.9. Others
15.4. Market Value Forecast, by Application, 2020-2035
- 15.4.1. Small Molecules
- 15.4.2. Monoclonal Antibodies
- 15.4.3. Vaccine
- 15.4.4. Cell & Gene Therapy
- 15.4.5. Others
15.5. Market Value Forecast, by End-user, 2020-2035
- 15.5.1. Pharmaceutical and Biotech Companies
- 15.5.2. Medical Device Manufacturers
15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Service Type
- 15.7.2. By Therapeutic Area
- 15.7.3. By Application
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis, by Company (2024)
16.3. Company Profiles
- 16.3.1. ICON plc
  - 16.3.1.1. Company Overview
  - 16.3.1.2. Financial Overview
  - 16.3.1.3. Product Portfolio
  - 16.3.1.4. Business Strategies
  - 16.3.1.5. Recent Developments
- 16.3.2. IQVIA
  - 16.3.2.1. Company Overview
  - 16.3.2.2. Financial Overview
  - 16.3.2.3. Product Portfolio
  - 16.3.2.4. Business Strategies
  - 16.3.2.5. Recent Developments
- 16.3.3. Thermo Fisher Scientific Inc.
  - 16.3.3.1. Company Overview
  - 16.3.3.2. Financial Overview
  - 16.3.3.3. Product Portfolio
  - 16.3.3.4. Business Strategies
  - 16.3.3.5. Recent Developments
- 16.3.4. SGS Life Sciences
  - 16.3.4.1. Company Overview
  - 16.3.4.2. Financial Overview
  - 16.3.4.3. Product Portfolio
  - 16.3.4.4. Business Strategies
  - 16.3.4.5. Recent Developments
- 16.3.5. Charles River Laboratories
  - 16.3.5.1. Company Overview
  - 16.3.5.2. Financial Overview
  - 16.3.5.3. Product Portfolio
  - 16.3.5.4. Business Strategies
  - 16.3.5.5. Recent Developments
- 16.3.6. Parexel
  - 16.3.6.1. Company Overview
  - 16.3.6.2. Financial Overview
  - 16.3.6.3. Product Portfolio
  - 16.3.6.4. Business Strategies
  - 16.3.6.5. Recent Developments
- 16.3.7. Syneos Health
  - 16.3.7.1. Company Overview
  - 16.3.7.2. Financial Overview
  - 16.3.7.3. Product Portfolio
  - 16.3.7.4. Business Strategies
  - 16.3.7.5. Recent Developments
- 16.3.8. Medpace
  - 16.3.8.1. Company Overview
  - 16.3.8.2. Financial Overview
  - 16.3.8.3. Product Portfolio
  - 16.3.8.4. Business Strategies
  - 16.3.8.5. Recent Developments
- 16.3.9. LabCorp
  - 16.3.9.1. Company Overview
  - 16.3.9.2. Financial Overview
  - 16.3.9.3. Product Portfolio
  - 16.3.9.4. Business Strategies
  - 16.3.9.5. Recent Developments
- 16.3.10. KCR
  - 16.3.10.1. Company Overview
  - 16.3.10.2. Financial Overview
  - 16.3.10.3. Product Portfolio
  - 16.3.10.4. Business Strategies
  - 16.3.10.5. Recent Developments
- 16.3.11. PRA Health Sciences
  - 16.3.11.1. Company Overview
  - 16.3.11.2. Financial Overview
  - 16.3.11.3. Product Portfolio
  - 16.3.11.4. Business Strategies
  - 16.3.11.5. Recent Developments
- 16.3.12. WuXi AppTec
  - 16.3.12.1. Company Overview
  - 16.3.12.2. Financial Overview
  - 16.3.12.3. Product Portfolio
  - 16.3.12.4. Business Strategies
  - 16.3.12.5. Recent Developments
- 16.3.13. Pharmaron
  - 16.3.13.1. Company Overview
  - 16.3.13.2. Financial Overview
  - 16.3.13.3. Product Portfolio
  - 16.3.13.4. Business Strategies
  - 16.3.13.5. Recent Developments
- 16.3.14. Avance Clinical
  - 16.3.14.1. Company Overview
  - 16.3.14.2. Financial Overview
  - 16.3.14.3. Product Portfolio
  - 16.3.14.4. Business Strategies
  - 16.3.14.5. Recent Developments
- 16.3.15. Pharmaron
  - 16.3.15.1. Company Overview
  - 16.3.15.2. Financial Overview
  - 16.3.15.3. Product Portfolio
  - 16.3.15.4. Business Strategies
  - 16.3.15.5. Recent Developments